Director, Regulatory Affairs CMC
Required skills
- Regulatory Affairs CMC
- global regulatory filings
- regulatory strategy
- CMC
- Supply Chain
- QA
- Chemistry
- Manufacturing
- Controls
- large molecules
Nice to have
- Mandarin Chinese
- electronic document management systems
- document review tools
Role summary
The Director, Regulatory Affairs, CMC is responsible for global regulatory filings, providing strategic input, and overseeing the preparation of submissions in collaboration with CMC, Supply Chain, and QA. This role guides CMC regulatory activities for assigned products through all development phases, managing the preparation and maintenance of CMC regulatory filings for clinical activities and marketing applications. Key responsibilities include developing and executing CMC regulatory strategies, managing submissions (IND, IMPD, BLA, MAA), representing Regulatory CMC in project teams, and interacting with Health Authorities. The position requires a Bachelor's degree in a science field, 10+ years of Regulatory CMC experience in biologics, and thorough knowledge of FDA, EU, and global regulations.
About Summit:
Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.
Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:
Non-small Cell Lung Cancer (NSCLC)
HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.
Colorectal Cancer (CRC)
HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.
Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.
Overview of Role:
The Director, Regulatory Affairs, CMC, is responsible for coordinating and preparing high-quality global regulatory filings. This role will provide regulatory strategy input and oversee preparation of regulatory submissions in collaboration with other stakeholders including CMC, Supply Chain and QA. The Director is responsible for providing regulatory guidance on Chemistry, Manufacturing and Controls (CMC) regulatory activities for assigned product(s) in coordination with key internal stakeholders. This role will manage regulatory CMC aspects of compounds (large molecules) through all phases of development and provide strategic and operational management of preparation and maintenance of CMC regulatory filings to support ongoing clinical activities as well as marketing applications.
Role and Responsibilities:
Experience, Education and Specialized Knowledge and Skills:
This is the pay for this position
Pay Transparency$190,000—$237,000 USDActual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.
Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.
Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.
Similar roles
- Executive Oncology Account Manager (North Dallas)Summit Therapeutics, Inc. · North Dallas, TX · Onsite
- Executive Oncology Account Manager (Buffalo)Summit Therapeutics, Inc. · Buffalo, NY · Onsite
- Sr Director, Regulatory Affairs CMC *PC 1626Miltenyi Biotec · Remote · Onsite
Senior Director, Regulatory Affairs CMCMadrigalpharma · Waltham -, PA · Hybrid- Senior Manager, Regulatory Affairs CMCFate Therapeutics · San Diego, CA · Onsite
- Senior Director, Regulatory Affairs CMC – Small MoleculeBeeline Medicines · Cambridge, MA · Hybrid
